Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1983-11-16
1992-08-11
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540363, 540364, 548251, C07D40114, C07D41714, C07D40304, A61K 3144
Patent
active
051378841
ABSTRACT:
N-tetrazolyl beta-lactams of the Formula: ##STR1## and the pharmaceutically acceptable salts thereof wherein R.sup.2 is hydrogen, alkyl having 1 to 6 carbon atoms or carboalkoxy having 2 to 7 carbon atoms; and
REFERENCES:
Derwent Abstract J6 0013 787A Toyama Chem. KK.
Klich et al Tetrahedron Letters, 25, 3849-3852 (1984).
Teutch Abstract #843 of the 1986 ICAAC (p. 252).
Derwent Abstract for aP114128 (1984).
Andrus et al Chem Abs 100, 209481K.
Derwent Patent Abstract 84325 D/46-BO3-SAGA 7.03.80 for Japan 56-125,360.
Andrus W. Alexander
Christensen Burton G.
Heck James V.
Berch Mark L.
Merck & Co. , Inc.
Pfeiffer Hesna J.
Speer Raymond M.
LandOfFree
N-tetrazolyl beta-lactams does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-tetrazolyl beta-lactams, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-tetrazolyl beta-lactams will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-346485